Oxford

Oxford - AstraZenca's COVID Vaccine Trial Data to be Released on Monday

According to an article published in The Lancet, “The Oxford vaccine candidate is already in large-scale Phase III human trials in Brazil to assess whether it can protect against COVID-19, but its developers have yet to report Phase I results.”